Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Linking compensation to payment incentives. A new challenge for healthcare.

Seymour D, Talbot KC, Stutelberg C.

Healthc Exec. 2014 Jul-Aug;29(4):58-60. No abstract available.

PMID:
25672112
2.

Relative absorption of tryptophan ethyl ester amide derivatives with various fatty acid chains in the dog.

Tse FL, Christiano JR, Talbot KC.

J Pharm Pharmacol. 1984 Sep;36(9):633-6.

PMID:
6149293
3.

The biotransformation of fluproquazone in man and several animal species.

Orwig BA, Dugger HA, Bhuta SI, Talbot KC, Schwarz HJ.

Arzneimittelforschung. 1981;31(5a):904-11.

PMID:
6973984
4.

Absorption, distribution, and excretion of fluproquazone in several animal species.

Williams JI, Bhuta SI, Jaffe JM, Migdalof BH, Schwarz HJ, Talbot KC, Brouillard JF, Donatsch P, Hodel C, Lemaire M, Meier J, Schweitzer A.

Arzneimittelforschung. 1981;31(5a):897-904. No abstract available.

PMID:
6973983
5.

Metabolism of butalbital, 5-allyl-5-isobutylbarbituric acid, in the dog.

Dain JG, Bhuta SI, Coombs RA, Talbot KC, Dugger HA.

Drug Metab Dispos. 1980 Jul-Aug;8(4):247-52.

PMID:
6105059
6.

Specific radioimmunoassay of ergot peptide alkaloids in plasma.

Schran HF, Schwarz HJ, Talbot KC, Loeffler LJ.

Clin Chem. 1979 Nov;25(11):1928-33. No abstract available.

7.

Biotransformation of mazindol. III. Comparison of metabolism in rat, dog, and man.

Dugger HA, Madrid VO, Talbot KC, Coombs RA, Orwig BA.

Drug Metab Dispos. 1979 May-Jun;7(3):132-7. No abstract available.

PMID:
38082

Supplemental Content

Loading ...
Support Center